This is a demo store. No orders will be fulfilled.

Sacituzumab govitecan (anti-TROP2), 肿瘤相关钙信号转导子 2 抗体

    应用:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • 宿主种属: 人(Human)
  • 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
  • 亚型: Human IgG1
  • 偶联: Mc-VC-PAB-SN38
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
Ab175650-100μg
100μg 现货 Stock Image
Ab175650-1mg
1mg 现货 Stock Image
Ab175650-5mg
5mg 现货 Stock Image
Ab175650-10mg
10mg 期货 Stock Image

基本信息

产品名称 Sacituzumab govitecan (anti-TROP2), 肿瘤相关钙信号转导子 2 抗体
别名 戈沙妥珠单抗 | 萨妥珠单抗戈维替康(抗肿瘤坏死因子 2)
英文别名 Cell surface glycoprotein Trop 2 antibody | Cell surface glycoprotein Trop-2 antibody | Cell surface glycoprotein Trop2 antibody | Epithelial glycoprotein 1 antibody | GA733 1 antibody | GA7331 antibody | M1S 1 antibody | M1S1 antibody | Membrane componen
规格或纯度 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥90%(SDS-PAGE&SEC-HPLC), 见COA
生化机理 May function as a growth factor receptor.
宿主种属 人(Human)
特异性 TACSTD2
种属反应性 人(Human),食蟹猴(Cynomolgus monkey)
偶联 Mc-VC-PAB-SN38
作用类型 结合剂
作用机制 肿瘤相关钙信号转导子 2 抗体

产品属性

克隆类型 重组抗体
Format Whole IgG
亚型 Human IgG1
轻链亚型 kappa
SDS-PAGE 145 kDa
纯化方法 Protein A purified
纯度 >90% (SDS-PAGE&SEC)
物理外观 Liquid
储存缓冲液 Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0
防腐剂 No
浓度 见COA
储存温度 -80℃储存,避免反复冻融
运输条件 超低温冰袋运输
稳定性与储存 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。
CAS编号和信息 1491917-83-9
分子类型 抗体偶联药物

关联靶点(人)

TACSTD2 Tclin 肿瘤相关钙信号转导子2(Tumor-associated calcium signal transducer 2) (0 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)

作用机制

作用机制 Action Type target ID Target Name Target Type Target Organism Binding Site Name 参考文献

图片

Sacituzumab govitecan (anti-TROP2) (Ab175650) - Flow Cytometry
Flow Cytometry analysis of MCF7 cells labelling TROP2 (red) with Sacituzumab govitecan (anti-TROP2) (Ab175650) at 1.0 μg/mL for 1 hour at 4°C. Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.

Sacituzumab govitecan (anti-TROP2) (Ab175650) - SEC
The purity of Sacituzumab govitecan (anti-TROP2) (Ab175650) is more than 95% verified by HPLC.

Sacituzumab govitecan (anti-TROP2) (Ab175650) - ELISA
Immobilized Recombinant huTROP2 (ECD)-chis protein at 2.0 μg/mL can bind Sacituzumab govitecan (anti-TROP2) (Ab175650) with the EC₅₀ of 5.81 ng/mL.

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!

找到4个结果

批号(Lot Number) 证书类型 货号
ZJ25F0927187 分析证书 Ab175650
ZJ25F0116772 分析证书 Ab175650
ZJ25F0116771 分析证书 Ab175650
ZJ25F0116770 分析证书 Ab175650

引用文献

1. Stoyanova T, Goldstein AS, Cai H, Drake JM, Huang J, Witte ON.  (2012)  Regulated proteolysis of Trop2 drives epithelial hyperplasia and stem cell self-renewal via β-catenin signaling..  Genes Dev,  26  (20): (2271-85).  [PMID:23070813]
2. Ocean AJ, Starodub AN, Bardia A, Vahdat LT, Isakoff SJ, Guarino M, Messersmith WA, Picozzi VJ, Mayer IA, Wegener WA et al..  (2017)  Sacituzumab govitecan (IMMU-132), an anti-Trop-2-SN-38 antibody-drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics..  Cancer,  123  (19): (3843-3854).  [PMID:28558150]
3. Sahota S, Vahdat LT.  (2017)  Sacituzumab govitecan: an antibody-drug conjugate..  Expert Opin Biol Ther,  17  (8): (1027-1031).  [PMID:28503956]
4. Stein R, Basu A, Goldenberg DM, Lloyd KO, Mattes MJ.  (1994)  Characterization of cluster 13: the epithelial/carcinoma antigen recognized by MAb RS7..  Int J Cancer Suppl,  (98-102).  [PMID:8194903]
5. Stein R, Basu A, Chen S, Shih LB, Goldenberg DM.  (1993)  Specificity and properties of MAb RS7-3G11 and the antigen defined by this pancarcinoma monoclonal antibody..  Int J Cancer,  55  (6): (938-46).  [PMID:8253531]

溶液计算器